BR112019011930A2 - medicamento, composição farmacêutica, método para prevenir, aliviar ou tratar transtorno bipolar em um indivíduo, e, uso de um composto de carbamato. - Google Patents
medicamento, composição farmacêutica, método para prevenir, aliviar ou tratar transtorno bipolar em um indivíduo, e, uso de um composto de carbamato. Download PDFInfo
- Publication number
- BR112019011930A2 BR112019011930A2 BR112019011930-2A BR112019011930A BR112019011930A2 BR 112019011930 A2 BR112019011930 A2 BR 112019011930A2 BR 112019011930 A BR112019011930 A BR 112019011930A BR 112019011930 A2 BR112019011930 A2 BR 112019011930A2
- Authority
- BR
- Brazil
- Prior art keywords
- bipolar disorder
- formula
- fact
- group
- carbamate compound
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Psychiatry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20160170224 | 2016-12-14 | ||
| PCT/KR2017/014740 WO2018111008A1 (ko) | 2016-12-14 | 2017-12-14 | 양극성 장애의 예방, 경감 또는 치료를 위한 카바메이트 화합물의 용도 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112019011930A2 true BR112019011930A2 (pt) | 2019-10-29 |
Family
ID=62559442
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112019011930-2A BR112019011930A2 (pt) | 2016-12-14 | 2017-12-14 | medicamento, composição farmacêutica, método para prevenir, aliviar ou tratar transtorno bipolar em um indivíduo, e, uso de um composto de carbamato. |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US11571410B2 (enExample) |
| EP (1) | EP3556366B1 (enExample) |
| JP (1) | JP7208139B2 (enExample) |
| KR (1) | KR102635938B1 (enExample) |
| CN (1) | CN110290788A (enExample) |
| AU (1) | AU2017374458B2 (enExample) |
| BR (1) | BR112019011930A2 (enExample) |
| CA (1) | CA3046297A1 (enExample) |
| CL (1) | CL2019001618A1 (enExample) |
| IL (1) | IL267195B2 (enExample) |
| MX (1) | MX2019006940A (enExample) |
| MY (1) | MY199104A (enExample) |
| WO (1) | WO2018111008A1 (enExample) |
| ZA (1) | ZA201903747B (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12070448B2 (en) * | 2018-09-21 | 2024-08-27 | Sk Biopharmaceuticals Co., Ltd. | Use of carbamate compound for prevention, alleviation or treatment of status epilepticus |
| US20220117941A1 (en) * | 2018-09-21 | 2022-04-21 | Sk Biopharmaceuticals Co., Ltd. | Carbamate compound and use of formulation comprising same in preventing, alleviating, or treating acute stress disorder or post-traumatic stress disorder |
| US20230000763A1 (en) * | 2019-11-22 | 2023-01-05 | Sk Biopharmaceuticals Co., Ltd. | Oral pharmaceutical composition comprising carbamate compound and preparation method therefor |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1154489C (zh) * | 1997-08-14 | 2004-06-23 | 弗·哈夫曼-拉罗切有限公司 | 抗神经学疾病的杂环乙烯基醚 |
| JP2004520263A (ja) * | 2000-07-21 | 2004-07-08 | テバ ファーマシューティカル インダストリーズ リミティド | 双極性障害における躁病を治療するためのバルプロ酸および２−バルプロエン酸アミド誘導体の使用 |
| BR0207832A (pt) | 2001-02-27 | 2004-06-22 | Ortho Mcneil Pharm Inc | Compostos de carbamato para uso na prevenção ou tratamento de distúrbio bipolar |
| CN1250215C (zh) * | 2001-02-27 | 2006-04-12 | 奥索-麦克尼尔药品公司 | 用于预防或治疗双相性精神障碍的氨基甲酸酯化合物 |
| EA200701065A1 (ru) | 2004-11-16 | 2007-12-28 | Элан Фарма Интернэшнл Лтд. | Инъецируемые составы, содержащие нанодисперсный оланзапин |
| US7598279B2 (en) * | 2005-04-22 | 2009-10-06 | Sk Holdings Co., Ltd. | Neurotherapeutic azole compounds |
| MX2009004798A (es) * | 2006-10-31 | 2009-08-12 | Janssen Pharmaceutica Nv | Tratamiento de los trastornos generalizados del desarrollo. |
| CA2765566C (en) | 2009-06-22 | 2016-04-12 | Sk Biopharmaceuticals Co., Ltd. | Method for preparation of carbamic acid (r)-1-aryl-2-tetrazolyl-ethyl ester |
| US8404461B2 (en) | 2009-10-15 | 2013-03-26 | SK Biopharmaceutical Co. Ltd. | Method for preparation of carbamic acid (R)-1-aryl-2-tetrazolyl-ethyl ester |
| US9610274B2 (en) * | 2010-06-30 | 2017-04-04 | Sk Biopharmaceuticals Co., Ltd. | Methods for treating bipolar disorder |
| ES2791186T3 (es) | 2014-08-15 | 2020-11-03 | Janssen Pharmaceuticals Inc | Triazoles como inhibidores de receptores NR2B |
-
2017
- 2017-12-14 KR KR1020197018408A patent/KR102635938B1/ko active Active
- 2017-12-14 CA CA3046297A patent/CA3046297A1/en active Pending
- 2017-12-14 AU AU2017374458A patent/AU2017374458B2/en active Active
- 2017-12-14 MY MYPI2019003348A patent/MY199104A/en unknown
- 2017-12-14 JP JP2019531623A patent/JP7208139B2/ja active Active
- 2017-12-14 CN CN201780077574.0A patent/CN110290788A/zh active Pending
- 2017-12-14 BR BR112019011930-2A patent/BR112019011930A2/pt unknown
- 2017-12-14 IL IL267195A patent/IL267195B2/en unknown
- 2017-12-14 US US16/468,782 patent/US11571410B2/en active Active
- 2017-12-14 MX MX2019006940A patent/MX2019006940A/es unknown
- 2017-12-14 EP EP17881161.8A patent/EP3556366B1/en active Active
- 2017-12-14 WO PCT/KR2017/014740 patent/WO2018111008A1/ko not_active Ceased
-
2019
- 2019-06-11 ZA ZA2019/03747A patent/ZA201903747B/en unknown
- 2019-06-12 CL CL2019001618A patent/CL2019001618A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA3046297A1 (en) | 2018-06-21 |
| KR102635938B1 (ko) | 2024-02-13 |
| AU2017374458A1 (en) | 2019-07-04 |
| IL267195A (enExample) | 2019-07-31 |
| CN110290788A (zh) | 2019-09-27 |
| MY199104A (en) | 2023-10-13 |
| US20190314337A1 (en) | 2019-10-17 |
| EP3556366A1 (en) | 2019-10-23 |
| ZA201903747B (en) | 2021-01-27 |
| JP7208139B2 (ja) | 2023-01-18 |
| CL2019001618A1 (es) | 2019-08-23 |
| JP2020502106A (ja) | 2020-01-23 |
| WO2018111008A1 (ko) | 2018-06-21 |
| EP3556366B1 (en) | 2025-10-22 |
| RU2019121913A (ru) | 2021-01-15 |
| EP3556366A4 (en) | 2020-06-17 |
| IL267195B2 (en) | 2024-05-01 |
| KR20190087572A (ko) | 2019-07-24 |
| US11571410B2 (en) | 2023-02-07 |
| RU2019121913A3 (enExample) | 2021-04-21 |
| IL267195B1 (en) | 2024-01-01 |
| AU2017374458B2 (en) | 2023-03-02 |
| MX2019006940A (es) | 2019-09-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7071287B2 (ja) | 繊維筋痛又は繊維筋痛の関連する機能的症候群を予防又は治療するためのカルバメート化合物の使用 | |
| BRPI0618239A2 (pt) | uso de flibanserina para o tratamento de distúrbios de desejo sexual pré-menopáusico | |
| JP2023086766A (ja) | 脆弱ｘ症候群、アンジェルマン症候群又はレット症候群を含む発達障害の軽減又は治療のためのカルバメート化合物の使用 | |
| BR112019011930A2 (pt) | medicamento, composição farmacêutica, método para prevenir, aliviar ou tratar transtorno bipolar em um indivíduo, e, uso de um composto de carbamato. | |
| ES2893456T3 (es) | Uso de un compuesto de carbamato para tratar preventivamente los dolores de cabeza | |
| CA2898279C (en) | Use of phenoxypropylamine compounds to treat sleep disorders | |
| IL274428B2 (en) | Use of a carbamate compound to prevent, relieve or treat a withdrawal seizure or epilepsy presenting with a withdrawal seizure | |
| EP3854391B1 (en) | Carbamate compound and use of formulation comprising same in preventing, alleviating, or treating acute stress disorder or post-traumatic stress disorder | |
| RU2774970C2 (ru) | Применение карбаматных соединений для профилактики, облегчения или лечения биполярного расстройства | |
| EP3556363B1 (en) | Use of carbamate compound for prevention, alleviation or treatment of pruritus | |
| HK40015213A (en) | Use of carbamate compounds for prevention, alleviation or treatment of bipolar disorder | |
| HK40005640A (en) | Use of carbamate compound for preventing or treating fibromyalgia or functional syndrome associated with fibromyalgia | |
| HK40005640B (en) | Use of carbamate compound for preventing or treating fibromyalgia or functional syndrome associated with fibromyalgia | |
| BR112018073556B1 (pt) | Uso de um composto de carbamato | |
| BR112019012000A2 (pt) | medicamento e composição farmacêutica para prevenção, alívio ou tratamento de tremor ou síndrome do tremor, método para prevenir, aliviar ou tratar tremor ou síndrome do tremor, e, uso de um composto de carbamato | |
| BRPI0611719A2 (pt) | uso farmacÊutico de uma 1-(3-clorofenil)-3-alquilpiperazina, e, composiÇço farmacÊutica |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B350 | Update of information on the portal [chapter 15.35 patent gazette] | ||
| B06W | Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] |